ARTICLE | Company News
HGSI, MEDX antibody deal
July 25, 2001 7:00 AM UTC
Human Genome Sciences and Medarex will use MEDX's UltiMAb technology to create human antibody leads specific to HGSI proteins. HGSI will have the option to license resulting therapeutic and diagnostic...